1196875-94-1Relevant academic research and scientific papers
NITROGENATED 5-MEMBERED HETEROCYCLIC COMPOUND
-
Page/Page column 50, (2011/01/12)
The purpose of the present invention is to provide a glucokinase activator which is useful as a pharmaceutical agent such as agents for the prophylaxis or treatment of diabetes, obesity and the like, and the like. The present invention is a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
Glucokinase Activators
-
Page/Page column 111-113, (2009/12/05)
Compounds are provided for use with glucokinase that comprise the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
